Fig. 4From: Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathologyEnhanced cognitive dysfunction, but not depression, in young adult microglial VPS35 deficient 5XFAD mice. a–c Open field test (OFT). Representative traces of mouse movement path in Ctrl:5XFAD mice and VPS35CX3CR1:5XFAD mice (3-MO) (a). Total distance traveled (b) and time spent inner zone (c) were shown (n = 6 male mice per group, mean ± SD). d–f Immobility time in forced swimming test (FST), tail suspension test (TST), and sucrose preference by sucrose preference test (SPT) were shown. The sucrose preference = consumed sucrose/total consumed liquid. (n = 6 male mice per group, mean ± SD). g–i Y-maze test. Schematic diagram (g), and reduced spontaneous alternations, but no the number of arm entries, in VPS35CX3CR1:5XFAD mice were shown (n = 6 male mice per group, mean ± SD, **P < 0.01). J–m Morris water maze (MWM) assay. Ctrl:5XFAD (n = 6) and VPS35CX3CR1:5XFAD (n = 6) male mice were examined. The VPS35CX3CR1:5XFAD mice exhibited increases in the latency and travel distance to the hidden platform (mean ± SD, *P < 0.05). n–o Motion trajectory in Ctrl:5XFAD mice and VPS35CX3CR1:5XFAD mice after removing hidden platform at day 6 (n), and quantification of the time spend in the hidden platform zone (o). (Mean ± SD, **P < 0.01, Student’s t test)Back to article page